SOD2 and hematocrit: MnSOD activity was statistically significantly higher in patients who died or achieved the combined endpoint (p < 0.05, p < 0.01), whereas CuZnSOD activity was statistically significantly higher only in HT patients as compared to patients who survived without endpoint during the 5-year follow-up (p < 0.05).